Intracoronary use of GP IIb/IIIa inhibitors in percutaneous coronary interventions
{{output}}
The glycoprotein (GP) IIb/IIIa receptor is critical to the process of platelet aggregation and thrombus formation as it serves as the final common pathway for platelet aggregation. For this reason, the development of GP IIb/IIIa inhibitors that block fibrinoge... ...
